Matches in SemOpenAlex for { <https://semopenalex.org/work/W2078426032> ?p ?o ?g. }
Showing items 1 to 51 of
51
with 100 items per page.
- W2078426032 endingPage "691" @default.
- W2078426032 startingPage "691" @default.
- W2078426032 abstract "Sir,It was interesting to read the article “Low-fluence photodynamic therapy” for early onset choroidal neovascular membrane (CNVM) following LASIK by Dr. George J Manayath et al.[1] The authors have to be commended for an excellent work. But I have some reservations that I would like to state.Were there any pathological myopia changes recorded by the refractive surgeon, prior to the refractive surgery? The time lapse between break in Bruch's membrane at the macula and appearance of CNVM is usually quite long. Often many weeks and not just 2 weeks. The break in Bruch's membrane can be induced by the stretch of the microkeratome, for a minute or so (the time the microkeratome suction ring exerts pressure) cannot be deduced from a single case study.I disagree with the author's statement that low fluence PDT is an alternative to intravitreal anti vegf anti-vascular endothelial growth factor (VEGF) injections for the following reasons.The anti vegf VEGF has been shown to be clearly superior to the PDT for the treatment of subfoveal CNVM in Myopia.[2] “The superior functional results of anti-VEGF drugs provide the reason for the first-line status of this treatment modality. Increasing safety data and consistent results of prospective pilot trials have proved photodynamic therapy to be inferior”.[3] Considering the cost of PDT and the ease of intraviteral injection, I would have expected the authors to try intravitreal injection of anti VEGF, rather than the inferior quality of treatment of low fluence PDT. Also statistics extracted from near by Retina Centre (Retina Institute of Karnataka, Bangalore) revealed that the PDT rate that used to be around 50 in 2004 has now come down to less than 6, in 2011, since the ubiquitous use of anti-VEGF. It is to the credit of the authors that they do mention in passing the anti-VEGF treatment for myopic choroidal neovscularization." @default.
- W2078426032 created "2016-06-24" @default.
- W2078426032 creator A5008554770 @default.
- W2078426032 date "2013-01-01" @default.
- W2078426032 modified "2023-09-26" @default.
- W2078426032 title "Low-fluence PDT better than anti-vascular endothelial growth factor" @default.
- W2078426032 doi "https://doi.org/10.4103/0301-4738.121181" @default.
- W2078426032 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3959102" @default.
- W2078426032 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24343601" @default.
- W2078426032 hasPublicationYear "2013" @default.
- W2078426032 type Work @default.
- W2078426032 sameAs 2078426032 @default.
- W2078426032 citedByCount "0" @default.
- W2078426032 crossrefType "journal-article" @default.
- W2078426032 hasAuthorship W2078426032A5008554770 @default.
- W2078426032 hasBestOaLocation W20784260321 @default.
- W2078426032 hasConcept C146285616 @default.
- W2078426032 hasConcept C167734588 @default.
- W2078426032 hasConcept C2777025900 @default.
- W2078426032 hasConcept C502942594 @default.
- W2078426032 hasConcept C71924100 @default.
- W2078426032 hasConceptScore W2078426032C146285616 @default.
- W2078426032 hasConceptScore W2078426032C167734588 @default.
- W2078426032 hasConceptScore W2078426032C2777025900 @default.
- W2078426032 hasConceptScore W2078426032C502942594 @default.
- W2078426032 hasConceptScore W2078426032C71924100 @default.
- W2078426032 hasIssue "11" @default.
- W2078426032 hasLocation W20784260321 @default.
- W2078426032 hasLocation W20784260322 @default.
- W2078426032 hasLocation W20784260323 @default.
- W2078426032 hasLocation W20784260324 @default.
- W2078426032 hasLocation W20784260325 @default.
- W2078426032 hasOpenAccess W2078426032 @default.
- W2078426032 hasPrimaryLocation W20784260321 @default.
- W2078426032 hasRelatedWork W2076049271 @default.
- W2078426032 hasRelatedWork W2078397784 @default.
- W2078426032 hasRelatedWork W2394080213 @default.
- W2078426032 hasRelatedWork W2735177792 @default.
- W2078426032 hasRelatedWork W3033141620 @default.
- W2078426032 hasRelatedWork W354908934 @default.
- W2078426032 hasRelatedWork W4237789507 @default.
- W2078426032 hasRelatedWork W4245266513 @default.
- W2078426032 hasRelatedWork W4254185523 @default.
- W2078426032 hasRelatedWork W4307908351 @default.
- W2078426032 hasVolume "61" @default.
- W2078426032 isParatext "false" @default.
- W2078426032 isRetracted "false" @default.
- W2078426032 magId "2078426032" @default.
- W2078426032 workType "article" @default.